<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110793">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01691365</url>
  </required_header>
  <id_info>
    <org_study_id>FMHS</org_study_id>
    <nct_id>NCT01691365</nct_id>
  </id_info>
  <brief_title>Effects of Antioxidants and B Vitamins Supplements on Inflammation in Obese Diabetic Patients</brief_title>
  <official_title>Oxidative Damage and Inflammation in Obese Diabetic Emirati Subjects Supplemented With Antioxidants and B-vitamins: a Randomized Placebo-controlled Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United Arab Emirates University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tawam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>United Arab Emirates University</source>
  <oversight_info>
    <authority>United Arab Emirates: Ain Medical District Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Substantial evidence shows that diets incorporating antioxidants and B-group vitamins can
      offer significant protection against infections and cardiovascular disease (CVD) especially
      in diabetic patients. The proposed study will determine whether improvements in antioxidants
      and B-group vitamins in diabetic patients who are known to have a high risk of CVD will lead
      to a clinical benefit
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following informed written consent 96 diabetic patients will be randomly assigned to receive
      either an oral dose of daily B-group vitamins (5 mg folic acid, 5mg vitamin B-2, 50 mg
      vitamin B-6, 0.4 mg vitamin B-12) and antioxidant vitamins [800 IU (727mg) of a-tocopherol
      and 500mg of vitamin C] [n=48], or no supplements [n= 48] daily for 90 days.  All subjects
      will have three assessments, at baseline, 3, and 12 months post-randomisation.  The
      assessment will include markers of inflammation, endothelial dysfunction, oxidative stress,
      antioxidants, total plasma homocysteine and risk of infections.  A fasting 15-ml of blood
      will be taken for measurements of total plasma homocysteine concentration, markers of
      inflammation, endothelial dysfunction, oxidative damage and vitamin concentrations.
      Further information on clinical variables which may influence endothelial dysfunction,
      antioxidant capacity, immunity and diabetes control status will be collected and adjusted
      for during analysis.

      Potential Significance- the study will help to clarify the temporal relationships between ,
      markers of inflammation, endothelial dysfunction and oxidative stress and risk of infections
      and form the basis of appropriate intervention strategies to minimise the long-term
      complications associated with type 2 diabetes mellitus.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Inflammation</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative damage</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Antioxidant status</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Infections</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Diabetes</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>vitamins pills</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>antioxidant and B vitamins vitamins vitamin
--------------------------------------------------------------------------------</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pills</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>MICROCRYSTALLINE CELLULOSE</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamins</intervention_name>
    <description>a capsule of antioxidant vitamins 221mg of alpha tocopherol and 167mg of vitamin C and B-group vitamins (1.67 mg folic acid, 1.67mg vitamin B-2, 20 mg vitamin B-6, 0.134 mg vitamin B-12) or an identical placebo daily for 90 days</description>
    <arm_group_label>vitamins pills</arm_group_label>
    <other_name>Antioxidants</other_name>
    <other_name>B vitamins</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo Capsule shell (Hydroxypropylmethyl cellulose, Hydroxypropylcellulose, Propylene glycol as stabilizer, Colour-Titanium dioxide)</description>
    <arm_group_label>pills</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes mellitus

        Exclusion Criteria:

          -  severe chronic clinical or psychiatric disease,

          -  participating in other intervention trials,

          -  on dietary supplements and

          -  those unable to give an informed written consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salah Gariballa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United Arab Emirates University</affiliation>
  </overall_official>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 19, 2012</lastchanged_date>
  <firstreceived_date>September 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>United Arab Emirates University</investigator_affiliation>
    <investigator_full_name>Salah Gariballa</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Antioxidant</keyword>
  <keyword>vitamins</keyword>
  <keyword>Diet</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
